Cargando…
Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
(1) Purpose: To retrospectively assess the technical and clinical outcome of patients with symptomatic postoperative fluid collections after pancreatic surgery, treated with CT-guided drainage (CTD). (2) Methods: 133 eligible patients between 2004 and 2017 were included. We defined technical success...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498101/ https://www.ncbi.nlm.nih.gov/pubmed/36140644 http://dx.doi.org/10.3390/diagnostics12092243 |
_version_ | 1784794673179525120 |
---|---|
author | Trumm, Christoph G. Hackner, Danilo Badmann, Katharina Crispin, Alexander Forbrig, Robert Ozpeynirci, Yigit Kuppinger, David Pedersen, Vera Liebig, Thomas Stahl, Robert |
author_facet | Trumm, Christoph G. Hackner, Danilo Badmann, Katharina Crispin, Alexander Forbrig, Robert Ozpeynirci, Yigit Kuppinger, David Pedersen, Vera Liebig, Thomas Stahl, Robert |
author_sort | Trumm, Christoph G. |
collection | PubMed |
description | (1) Purpose: To retrospectively assess the technical and clinical outcome of patients with symptomatic postoperative fluid collections after pancreatic surgery, treated with CT-guided drainage (CTD). (2) Methods: 133 eligible patients between 2004 and 2017 were included. We defined technical success as the sufficient drainage of the fluid collection(s) and the absence of peri-interventional complications (minor or major according to SIR criteria). Per definition, clinical success was characterized by normalization of specific blood parameters within 30 days after the intervention or a decrease by at least 50% without requiring additional surgical revision. C-reactive protein (CRP), Leukocytes, Interleukin-6, and Dose length product (DLP) for parts of the intervention were determined. (3) Results: 97.0% of 167 interventions were technically successful. Clinical success was achieved in 87.5% of CRP, in 78.4% of Leukocytes, and in 87.5% of Interleukin-6 assessments. The median of successful decrease was 6 days for CRP, 5 days for Leukocytes, and 2 days for Interleukin-6. No surgical revision was necessary in 93.2%. DLP was significantly lower in the second half of the observation period (total DLP: median 621.5 mGy*cm between 2011–2017 vs. median 944.5 mGy*cm between 2004–2010). (4) Conclusions: Technical success rate of CTD was very high and the clinical success rate was fair to good. Given an elderly and multimorbid patient cohort, CTD can have a temporizing effect in the postoperative period after pancreatic surgery. Reducing the radiation dose over time might reflect developments in CT technology and increased experience of interventional radiologists. |
format | Online Article Text |
id | pubmed-9498101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94981012022-09-23 Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period Trumm, Christoph G. Hackner, Danilo Badmann, Katharina Crispin, Alexander Forbrig, Robert Ozpeynirci, Yigit Kuppinger, David Pedersen, Vera Liebig, Thomas Stahl, Robert Diagnostics (Basel) Article (1) Purpose: To retrospectively assess the technical and clinical outcome of patients with symptomatic postoperative fluid collections after pancreatic surgery, treated with CT-guided drainage (CTD). (2) Methods: 133 eligible patients between 2004 and 2017 were included. We defined technical success as the sufficient drainage of the fluid collection(s) and the absence of peri-interventional complications (minor or major according to SIR criteria). Per definition, clinical success was characterized by normalization of specific blood parameters within 30 days after the intervention or a decrease by at least 50% without requiring additional surgical revision. C-reactive protein (CRP), Leukocytes, Interleukin-6, and Dose length product (DLP) for parts of the intervention were determined. (3) Results: 97.0% of 167 interventions were technically successful. Clinical success was achieved in 87.5% of CRP, in 78.4% of Leukocytes, and in 87.5% of Interleukin-6 assessments. The median of successful decrease was 6 days for CRP, 5 days for Leukocytes, and 2 days for Interleukin-6. No surgical revision was necessary in 93.2%. DLP was significantly lower in the second half of the observation period (total DLP: median 621.5 mGy*cm between 2011–2017 vs. median 944.5 mGy*cm between 2004–2010). (4) Conclusions: Technical success rate of CTD was very high and the clinical success rate was fair to good. Given an elderly and multimorbid patient cohort, CTD can have a temporizing effect in the postoperative period after pancreatic surgery. Reducing the radiation dose over time might reflect developments in CT technology and increased experience of interventional radiologists. MDPI 2022-09-16 /pmc/articles/PMC9498101/ /pubmed/36140644 http://dx.doi.org/10.3390/diagnostics12092243 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Trumm, Christoph G. Hackner, Danilo Badmann, Katharina Crispin, Alexander Forbrig, Robert Ozpeynirci, Yigit Kuppinger, David Pedersen, Vera Liebig, Thomas Stahl, Robert Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period |
title | Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period |
title_full | Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period |
title_fullStr | Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period |
title_full_unstemmed | Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period |
title_short | Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period |
title_sort | low-milliampere ct fluoroscopy-guided percutaneous drainage placement after pancreatic surgery: technical and clinical outcome in 133 consecutive patients during a 14-year period |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498101/ https://www.ncbi.nlm.nih.gov/pubmed/36140644 http://dx.doi.org/10.3390/diagnostics12092243 |
work_keys_str_mv | AT trummchristophg lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT hacknerdanilo lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT badmannkatharina lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT crispinalexander lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT forbrigrobert lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT ozpeynirciyigit lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT kuppingerdavid lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT pedersenvera lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT liebigthomas lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod AT stahlrobert lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod |